CD8A and neoplasm: Inducible co-stimulator of T cells agonist (ICOS) is an immunosuppressive stimulator that upregulates Tregs, though it also has been shown to have anti-tumor immune action when the same pathway is activated in cytotoxic CD8+ T cells [125,126].